BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31488063)

  • 1. Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study.
    Moosa A; Gengiah TN; Lewis L; Naidoo K
    BMC Infect Dis; 2019 Sep; 19(1):775. PubMed ID: 31488063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
    Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K
    J Int AIDS Soc; 2018 Jun; 21(6):e25112. PubMed ID: 29890048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.
    Kehoe K; Boulle A; Tsondai PR; Euvrard J; Davies MA; Cornell M
    J Int AIDS Soc; 2020 May; 23(5):e25476. PubMed ID: 32406983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa.
    Fatti G; Mothibi E; Shaikh N; Grimwood A
    AIDS Care; 2016 Nov; 28(11):1365-72. PubMed ID: 27251459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study.
    Dorward J; Sookrajh Y; Gate K; Khubone T; Mtshaka N; Mlisana K; Ngobese H; Yende-Zuma N; Garrett N
    J Int AIDS Soc; 2020 Apr; 23(4):e25479. PubMed ID: 32319203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "My future is bright…I won't die with the cause of AIDS": ten-year patient ART outcomes and experiences in South Africa.
    Hendrickson CJ; Pascoe SJS; Huber AN; Moolla A; Maskew M; Long LC; Fox MP
    J Int AIDS Soc; 2018 Oct; 21(10):e25184. PubMed ID: 30318848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Adherence to Antiretroviral Therapy in a Rural Paediatric Cohort in KwaZulu-Natal, South Africa.
    Smith C; Gengiah TN; Yende-Zuma N; Upfold M; Naidoo K
    AIDS Behav; 2016 Nov; 20(11):2729-2738. PubMed ID: 27289369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Uganda.
    Matthews LT; Orrell C; Bwana MB; Tsai AC; Psaros C; Asiimwe S; Amanyire G; Musinguzi N; Bell K; Bangsberg DR; Haberer JE;
    J Int AIDS Soc; 2020 Aug; 23(8):e25586. PubMed ID: 32820622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
    Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
    Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes.
    Moorhouse M; Maartens G; Venter WDF; Moosa MY; Steegen K; Jamaloodien K; Fox MP; Conradie F
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):73-78. PubMed ID: 30334876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
    J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of Early Antiretroviral Therapy Among South African Women.
    Garrett N; Norman E; Leask K; Naicker N; Asari V; Majola N; Karim QA; Karim SSA
    AIDS Behav; 2018 Mar; 22(3):1018-1024. PubMed ID: 28224322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
    Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
    PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.
    Bekker LG; Myer L; Orrell C; Lawn S; Wood R
    S Afr Med J; 2006 Apr; 96(4):315-20. PubMed ID: 16670804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
    Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
    Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.
    Leisegang R; Cleary S; Hislop M; Davidse A; Regensberg L; Little F; Maartens G
    PLoS Med; 2009 Dec; 6(12):e1000189. PubMed ID: 19956658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.